Copyright
©2010 Baishideng.
World J Gastroenterol. May 21, 2010; 16(19): 2407-2410
Published online May 21, 2010. doi: 10.3748/wjg.v16.i19.2407
Published online May 21, 2010. doi: 10.3748/wjg.v16.i19.2407
Figure 1 Time course of median serum levels of alkaline phosphatase (ALP) in patients with sustained virological response (SVR) and patients with relapse.
A: All patients with genotypes 1-3 from week 0 to week 24. The 36 and 48 wk values exclusively represent genotype 1 patients (n = 52), as patients with genotypes 2 and 3 were only treated for 24 wk; B: Genotype 1 patients, only. aP < 0.05 vs SVR; cP < 0.005 vs SVR; eP < 0.05 vs baseline. p.t.: Post treatment.
- Citation: Bodlaj G, Hubmann R, Saleh K, Stojakovic T, Biesenbach G, Berg J. Alkaline phosphatase predicts relapse in chronic hepatitis C patients with end-of-treatment response. World J Gastroenterol 2010; 16(19): 2407-2410
- URL: https://www.wjgnet.com/1007-9327/full/v16/i19/2407.htm
- DOI: https://dx.doi.org/10.3748/wjg.v16.i19.2407